Preventing early ventilator infections after severe brain injury
Official title: PRophylaxis Against Early VENTilator-associated Infections to Reduce Mortality in Mechanically Ventilated Intensive Care Unit (ICU) Patients With Acute Brain Injuries: a Phase 3 Randomised, Double Blind, Parallel Group, Placebo-controlled Two-side Superiority Trial
Run by The George Institute · NCT06819592 · Data updated 2026-11-12
This will test whether giving a single dose of the antibiotic ceftriaxone soon after starting mechanical ventilation can prevent lung infections and help adults with severe acute brain injury survive.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3300 (estimated) |
| Sponsor | The George Institute Academic / other |
| Locations | 29 sites (Canberra, Australian Capital Territory and 28 other locations) |
| Status | Recruiting |
| Started | October 30, 2025 |
| Main results expected | August 2029 |
| Study ends | December 2029 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT06819592 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) who are invasively mechanically ventilated for an acute severe brain injury (stroke, traumatic brain injury, hypoxic brain injury after cardiac arrest, intracranial haemorrhage, subarachnoid haemorrhage, or cerebral venous sinus thrombosis) and who can receive the intervention within the trial time windows are ideal candidates.
✕Probably not a fit
Patients intubated more than 12 hours earlier, admitted more than 72 hours earlier, already on or recently treated with systemic antibiotics, pregnant patients, or those with contraindications to ceftriaxone are unlikely to benefit from joining this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with recent severe brain injury who require invasive mechanical ventilation are randomly assigned to receive either a single 2 g dose of ceftriaxone or placebo shortly after intubation. The trial compares rates of early ventilator-associated lower respiratory tract infection, death, and functional outcomes between groups. Patients treated at participating ICUs in New South Wales are enrolled within a strict time window (intubation within 12 hours, hospital admission within 72 hours). Standard ICU care is continued for all patients while outcomes are followed for mortality and quality of life measures.
Why it matters
Potential benefit: If successful, this approach could lower early ventilator-associated pneumonia rates and improve survival and recovery after severe brain injury.
How similar studies have gone: Prior single-center pilot trials and at least one multicentre randomized trial (including the PROPHY-VAP and a trial after out-of-hospital cardiac arrest) have shown that early prophylactic antibiotics can reduce rates of early ventilator-associated pneumonia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥ 18 years of age 2. Receiving invasive mechanical ventilation 3. The requirement for mechanical ventilation is because of an acute brain injury due to intracranial haemorrhage, ischaemic stroke, cerebral venous sinus thrombosis, subarachnoid haemorrhage, suspected hypoxic ischaemic encephalopathy post cardiac arrest, or traumatic brain injury. 4. Admitted to an ICU or is anticipated to be admitted to an ICU Exclusion Criteria: 1. Endotracheal intubation was more than 12 hours ago 2. Hospital admission was more than 72 hours ago 3. Anticipated inability to deliver trial intervention within 90 minutes of randomisation 4. Documented use of antibiotic therapy in the week prior to hospitalisation 5. Currently receiving antibiotic therapy, or intention to prescribe antibiotic therapy, excluding cephazolin for peri-operative prophylaxis 6. Any contraindication to receiving ceftriaxone 7. Known or suspected pregnancy 8. Death within 90 days is deemed inevitable due to the current illness or intercurrent medical conditions 9. Previously enrolled in the PREVENT-NEURO trial.
Where it's running
-
Nepean Hospital
Kingswood, New South Wales, Australia Recruiting -
St George Hospital
Kogarah, New South Wales, Australia Recruiting -
Royal North Shore Hospital
Sydney, New South Wales, Australia Recruiting -
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia Recruiting -
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia Recruiting -
Wellington Hospital
Wellington, New Zealand Recruiting
Show 23 more locations
-
Canberra Hospital
Canberra, Australian Capital Territory, Australia Not yet recruiting -
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia Not yet recruiting -
St. Vincent's Health Sydney
Darlinghurst, New South Wales, Australia Not yet recruiting -
Dubbo Health Service
Dubbo, New South Wales, Australia Not yet recruiting -
Liverpool Hospital
Liverpool, New South Wales, Australia Not yet recruiting -
The George Institute
Randwick, New South Wales, Australia Not yet recruiting -
Westmead Hospital
Westmead, New South Wales, Australia Not yet recruiting -
Royal Darwin Hospital
Tiwi, Northern Territory, Australia Not yet recruiting -
Townsville University Hospital
Douglas, Queensland, Australia Not yet recruiting -
Gold Coast University Hospital
Gold Coast, Queensland, Australia Not yet recruiting -
Royal Adelaide Hospital
Adelaide, South Australia, Australia Not yet recruiting -
Royal Hobart Hospital
Hobart, Tasmania, Australia Not yet recruiting -
Bendigo Health
Bendigo, Victoria, Australia Not yet recruiting -
Eastern Health Box Hill
Box Hill, Victoria, Australia Not yet recruiting -
St Vincent's Hospital Melbourne
Fitzroy, Victoria, Australia Not yet recruiting -
Footscray Hospital Western Health
Footscray, Victoria, Australia Not yet recruiting -
Austin Health
Heidelberg, Victoria, Australia Not yet recruiting -
The Alfred Hospital
Melbourne, Victoria, Australia Not yet recruiting -
Sunshine Hospital - Western Health
Saint Albans, Victoria, Australia Not yet recruiting -
Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia Not yet recruiting -
Royal Perth Hospital
Perth, Western Australia, Australia Not yet recruiting -
Fiona Stanley Hospital
Perth, Western Australia, Australia Not yet recruiting -
University of Alberta
Edmonton, Alberta, Canada Not yet recruiting
Study contacts
- Principal investigator: Andrew Udy, Prof — The Alfred
- Study coordinator: Tina Schneider
- Email: tschneider@georgeinstitute.org.au
- Phone: +61 02 8052 4562
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut microbes and blood signals in sepsis-related liver and kidney injury
This study tests whether gut microbes and blood markers differ in adults with sepsis who develop liver or kidney injury, compared with healthy volunteers.
-
Brain monitoring during ventilator therapy in critically ill patients
This study tests how lung-directed ventilator adjustments affect brain activity and blood flow in adults with acute brain injury who need mechanical ventilation.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
Neutral fluid balance in adults with traumatic brain injury (LIMIT-TBI)
This study tests whether keeping daily fluid balance around zero (within 500 mL) for the first 5 days in the ICU is feasible and safe for adults with traumatic brain injury.
-
Portable MRI for kids with hypoxic brain injury
This study tests whether a bedside, low-field portable MRI can accurately detect hypoxic-ischemic brain injuries in children compared with standard imaging.
-
100-Year Human Aging and Longevity Tracking Program
This project will follow adults over their lifetimes to see if repeated health tests can predict lifespan, causes of death, serious disease, and loss of function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.